Publications: Dr Elizabeth Nally

Bergerot CD, Bergerot PG, Castro DV, Mercier B, Nally E, Ali A, Hutson TE, Bex A et al. ( 2025 ) . Development of a FKSI-23: A new bespoke health-related quality of life (HRQOL) questionnaire for the advanced and adjuvant setting in renal cell carcinoma (RCC) . Journal of Clinical Oncology vol. 43 , ( 5_suppl ) 526 - 526 .

Nally E, Ainsworth G, Brown SR, Bergerot CD, Wells C, Young MN, Westerman T, Coca S et al. ( 2025 ) . Improving health related quality of life (HRQoL) assessment and immune related adverse event (irAE) classification with novel tools in renal cancer . Journal of Clinical Oncology vol. 43 , ( 5_suppl ) 525 - 525 .

Wells C, Nally E, Jackson-Spence F, Coca S, Westerman T, Young MN, Szabados BE, Powles T ( 2025 ) . Systemic therapy clinical trial participation in patients with bladder and kidney cancers . Journal of Clinical Oncology vol. 43 , ( 5_suppl ) 451 - 451 .

Semaan K, Nawfal R, Nally E, Janjigian YY, Robert C, Peters S, Powles T, Choueiri TK ( 2024 ) . Landscape of subsequent therapies in perioperative immunotherapy trials across multiple cancer types . The Lancet Oncology vol. 26 , ( JAMA Netw Open 7 2024 ) 161 - 164 .

Nally E, Young M, Wells C, Fairhead R, Baines K, Cheney-Lowe H, Jackson-Spence F, Powles T ( 2024 ) . Is HER2 the New NECTIN4 in Advanced Urothelial Cancer? . European Urology Focus vol. 10 , ( 2 ) 219 - 221 .

Nally E, Young M, Chauhan V, Wells C, Szabados B, Powles T, Jackson-Spence F ( 2024 ) . Upper Tract Urothelial Carcinoma (UTUC): Prevalence, Impact and Management Challenge . Cancer Management and Research vol. 16 , ( 0 ) 467 - 475 .

Bergerot CD, Castro DV, Bergerot PG, Mercier BD, Nally E, Ali AA, Philip EJ, Buso M et al. ( 2024 ) . Development of a patient-centered health-related quality of life (HRQOL) measure for metastatic renal cell carcinoma (mRCC): A three-phase study . Journal of Clinical Oncology vol. 42 , ( 4_suppl ) 365 - 365 .